Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

Affiliations

• ¹ Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
• ² Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
• ³ Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
• ⁴ Duke University Medical Center, Durham, North Carolina, USA.
• ⁵ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
• ⁶ Division of Infectious Diseases Department of Medicine, Irvine School of Medicine, University of California, Irvine, California, USA.
• ⁷ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
• ⁸ Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
• ⁹ Sanofi Pasteur, Swiftwater, Pennsylvania, USA.
• ¹⁰ Novartis Vaccines and Diagnostics, Inc., Cambridge, Massachusetts, USA.
• ¹¹ Advanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
• ¹² EuroVacc Foundation, Lausanne, Switzerland.
• ¹³ Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
• ¹⁴ Institute of Clinical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
• ¹⁵ School of Life Sciences, Arizona State University, Tempe, Arizona, USA.